Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World check on Long-Term asthma drug safety

NCT ID NCT03588546

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aimed to monitor the long-term safety and effectiveness of the asthma medication FASENRA in real-world patients. It involved 653 people with severe asthma that was hard to control with other treatments. The main goal was to track any side effects and see how well the drug helped control asthma symptoms over a long period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Aichi, D3250C00057, Japan

  • Research Site

    Akita, D3250C00057, Japan

  • Research Site

    Aomori, D3250C00057, Japan

  • Research Site

    Chiba, D3250C00057, Japan

  • Research Site

    Ehime, D3250C00057, Japan

  • Research Site

    Fukuoka, D3250C00057, Japan

  • Research Site

    Gunma, D3250C00057, Japan

  • Research Site

    Hiroshima, D3250C00057, Japan

  • Research Site

    Hokkaido, D3250C00057, Japan

  • Research Site

    Hyōgo, D3250C00057, Japan

  • Research Site

    Ibaraki, D3250C00057, Japan

  • Research Site

    Kagawa, D3250C00057, Japan

  • Research Site

    Kagoshima, D3250C00057, Japan

  • Research Site

    Kanagawa, D3250C00057, Japan

  • Research Site

    Kumamoto, D3250C00057, Japan

  • Research Site

    Kyoto, D3250C00057, Japan

  • Research Site

    Mie, D3250C00057, Japan

  • Research Site

    Miyagi, D3250C00057, Japan

  • Research Site

    Numakunai, D3250C00057, Japan

  • Research Site

    Okayama, D3250C00057, Japan

  • Research Site

    Okinawa, D3250C00057, Japan

  • Research Site

    Osaka, D3250C00057, Japan

  • Research Site

    Ōita, D3250C00057, Japan

  • Research Site

    Saitama, D3250C00057, Japan

  • Research Site

    Shiga, D3250C00057, Japan

  • Research Site

    Tochigi, D3250C00057, Japan

  • Research Site

    Tokyo, D3250C00057, Japan

  • Research Site

    Yamagata, D3250C00057, Japan

  • Research Site

    Yamaguchi, D3250C00057, Japan

Conditions

Explore the condition pages connected to this study.

ASTHMA